ViaDerma Inc (VDRM)

[why_meil]

I agree. But any sale is a good sale. Amazon certainly won't be their core sales channel, but it's still a decent selling platform for retail and good for getting the word out.

The real money to be made though will be wholesale volume sales to their distributors.

And I'm most interested in seeing if VDRM can develop that cannabis product sometime in 2018 to take advantage of the medical MMJ opportunity in Canada that they mentioned. That alone can be huge and dwarf Japan sales of Vitastem. But in my opinion the cannabis product won't be ready in 2018, otherwise Otiko would have mentioned the potential revenues from it when he was projecting sales for 2018.

Lots of potential here IF VDRM can execute. Right now it's mostly talk. Although, after 8 years it appears Vitastem finally made it to market. Other products to follow hopefully in 2018. This could be interesting.